Shares of gene-editing startup Beam jump 40% after upsized IPO
February 06, 2020 at 12:30 PM EST
Beam Therapeutics raised 80% more than initially planned when it closed its IPO Thursday, just one week after a neighboring company doubled its market launch goal.
